Logo image of PAVM

PAVMED INC (PAVM) Stock Price, Quote, News and Overview

NASDAQ:PAVM - Nasdaq - US70387R4039 - Common Stock - Currency: USD

0.6008  -0.01 (-2.39%)

PAVM Quote, Performance and Key Statistics

PAVMED INC

NASDAQ:PAVM (5/30/2025, 8:25:12 PM)

0.6008

-0.01 (-2.39%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
Statistics
52 Week High1.9
52 Week Low0.55
Market Cap10.59M
Shares17.62M
Float13.70M
Yearly DividendN/A
Dividend YieldN/A
PE0.68
Fwd PEN/A
Earnings (Next)08-11 2025-08-11
IPO07-27 2016-07-27


PAVM short term performance overview.The bars show the price performance of PAVM in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -10 -20 -30

PAVM long term performance overview.The bars show the price performance of PAVM in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of PAVM is 0.6008 USD. In the past month the price decreased by -26.73%. In the past year, price decreased by -58.57%.

PAVMED INC / PAVM Daily stock chart

PAVM Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 27.95 232.41B
ISRG INTUITIVE SURGICAL INC 72.3 197.97B
BSX BOSTON SCIENTIFIC CORP 38.99 155.73B
SYK STRYKER CORP 30.54 146.23B
MDT MEDTRONIC PLC 15.09 106.43B
BDX BECTON DICKINSON AND CO 12.25 49.47B
EW EDWARDS LIFESCIENCES CORP 30.08 45.88B
IDXX IDEXX LABORATORIES INC 45.03 41.60B
RMD RESMED INC 26.96 35.89B
DXCM DEXCOM INC 52 33.64B
GEHC GE HEALTHCARE TECHNOLOGY 15.33 32.30B
STE STERIS PLC 26.25 24.09B

About PAVM

Company Profile

PAVM logo image PAVmed, Inc. is a commercial-stage technology medical device company, which engages in the commercialization of medical technologies. The company is headquartered in New York City, New York and currently employs 39 full-time employees. The company went IPO on 2016-07-27. The firm operates in the medical devices, diagnostics, and digital health sectors. Its subsidiary includes Lucid Diagnostics Inc., which is a commercial-stage cancer prevention medical diagnostics company that markets the EsoGuard Esophageal DNA Test and EsoCheck Esophageal Cell Collection Device for early detection of esophageal precancer to prevent esophageal cancer deaths. EsoCheck is a noninvasive swallowable balloon capsule catheter device capable of sampling surface esophageal cells. EsoGuard is a bisulfite-converted next-generation sequencing (NGS) DNA assay performed on surface esophageal cells collected with EsoCheck. Its other subsidiary, Veris Health Inc., is a digital health company focused on enhanced personalized cancer care through remote patient monitoring using implantable biologic sensors with wireless communication along with a custom suite of connected external devices.

Company Info

PAVMED INC

360 Madison Avenue, 25th Floor

New York City NEW YORK 10165 US

CEO: Lishan Aklog

Employees: 39

PAVM Company Website

PAVM Investor Relations

Phone: 12129494319

PAVMED INC / PAVM FAQ

What is the stock price of PAVMED INC today?

The current stock price of PAVM is 0.6008 USD. The price decreased by -2.39% in the last trading session.


What is the ticker symbol for PAVMED INC stock?

The exchange symbol of PAVMED INC is PAVM and it is listed on the Nasdaq exchange.


On which exchange is PAVM stock listed?

PAVM stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for PAVMED INC stock?

8 analysts have analysed PAVM and the average price target is 11.99 USD. This implies a price increase of 1894.84% is expected in the next year compared to the current price of 0.6008. Check the PAVMED INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is PAVMED INC worth?

PAVMED INC (PAVM) has a market capitalization of 10.59M USD. This makes PAVM a Nano Cap stock.


How many employees does PAVMED INC have?

PAVMED INC (PAVM) currently has 39 employees.


What are the support and resistance levels for PAVMED INC (PAVM) stock?

PAVMED INC (PAVM) has a support level at 0.58 and a resistance level at 0.63. Check the full technical report for a detailed analysis of PAVM support and resistance levels.


Is PAVMED INC (PAVM) expected to grow?

The Revenue of PAVMED INC (PAVM) is expected to decline by -95.85% in the next year. Check the estimates tab for more information on the PAVM EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy PAVMED INC (PAVM) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does PAVMED INC (PAVM) stock pay dividends?

PAVM does not pay a dividend.


When does PAVMED INC (PAVM) report earnings?

PAVMED INC (PAVM) will report earnings on 2025-08-11.


What is the Price/Earnings (PE) ratio of PAVMED INC (PAVM)?

The PE ratio for PAVMED INC (PAVM) is 0.68. This is based on the reported non-GAAP earnings per share of 0.88 and the current share price of 0.6008 USD. Check the full fundamental report for a full analysis of the valuation metrics for PAVM.


What is the Short Interest ratio of PAVMED INC (PAVM) stock?

The outstanding short interest for PAVMED INC (PAVM) is 1.77% of its float. Check the ownership tab for more information on the PAVM short interest.


PAVM Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

PAVM Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to PAVM. PAVM may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

PAVM Financial Highlights

Over the last trailing twelve months PAVM reported a non-GAAP Earnings per Share(EPS) of 0.88. The EPS increased by 109.85% compared to the year before.


Industry RankSector Rank
PM (TTM) 3635.17%
ROA 137.15%
ROE 154.17%
Debt/Equity 0.14
Chartmill High Growth Momentum
EPS Q2Q%112.98%
Sales Q2Q%-99.21%
EPS 1Y (TTM)109.85%
Revenue 1Y (TTM)-33.98%

PAVM Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 83% to PAVM. The Buy consensus is the average rating of analysts ratings from 8 analysts.

For the next year, analysts expect an EPS growth of 72.05% and a revenue growth -95.85% for PAVM


Ownership
Inst Owners12.85%
Ins Owners9.42%
Short Float %1.77%
Short Ratio1.86
Analysts
Analysts82.5
Price Target11.99 (1895.67%)
EPS Next Y72.05%
Revenue Next Year-95.85%